- Optimization of affinity chromatography of pepsins on lodinated L-tyrosine-Sepharose2008 | Faculty of Science
- Optimization of affinity chromatography of pepsins on lodinated L-Tyrosine-Sepharose2008 | First Faculty of Medicine
- Optimization of affinity chromatography of pepsins on Iodinated L-tyrosine-Sepharose2007 | Faculty of Science
- Optimalization of affinity chromatography of pepsins on iodinated L- tyrosine-sepharosePublication without faculty affiliation
- Novel Mutations in the Tyrosine Hydroxylase Gene in the First Czech Patient with Tyrosine Hydroxylase Deficiency2012 | First Faculty of Medicine
- Affinity chromatography of porcine pepsin on different types of immobilized diiodo-L-tyrosine2001 | Faculty of Science
- The 14-3-3 Protein Affects the Conformation of the Regulatory Domain of Human Tyrosine Hydroxylase2008 | Faculty of Mathematics and Physics
- The role of tyrosine transposases in evolution of bacterial palindromic genomic repeats.Publication without faculty affiliation
- Expression patterns of Src-family tyrosine kinases during Xenopus laevis development2009 | First Faculty of Medicine
- Agonist-induced tyrosine phosphorylation of Gq/G11 alpha requires the intact structure of membrane domains2005 | Faculty of Science
- Incidence of second malignancies during treatment of chronic myeloid leukemia with tyrosine kinase inhibitors in the Czech Republic and Slovakia2011 | Faculty of Medicine in Hradec Králové
- ARHGAP42 is activated by Src-mediated tyrosine phosphorylation to promote cell motility2017 | Faculty of Science
- Tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma2020 | First Faculty of Medicine
- Presence of ecto-protein tyrosine phosphatase activity is vital for survival of Setaria cervi, a bovine filarial parasite2014 | Third Faculty of Medicine
- Current approach for chronic myeloid leukemia treatment with tyrosin kinase inhibitors2016 | First Faculty of Medicine
- Termination of the treatment in chronic myeloid leukemia - possi bility of stopping the tyrosine kinase inhibitors2017 | First Faculty of Medicine
- ABL1, SRC and other non-receptor tyrosine-kinases as new targets for specific anticancer therapy2010 | First Faculty of Medicine
- Regulation of Cys-based protein tyrosine phosphatases via reactive oxygen and nitrogen species in mast cells and basophils2005 | Third Faculty of Medicine
- Discontinuation of biological therapy with tyrosine kinase inhibitors in chronic myeloid leukemia patients2014 | Faculty of Medicine in Pilsen
- Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia patients - worldwide battlefield2015 | Faculty of Medicine in Pilsen
- Light-Driven Tyrosine Radical Formation in a Ruthenium-Tyrosine Complex Attached to Nanoparticle TiO22002 | Publication without faculty affiliation
- Lincomycin Biosynthesis Involves a Tyrosine Hydroxylating Heme Protein of an Unusual Enzyme Family2013 | Faculty of Mathematics and Physics
- Down-regulation of Protein-tyrosine Phosphatases Activates an Immune Receptor in the Absence of Its Translocation into Lipid Rafts2010 | Third Faculty of Medicine
- Bruton's tyrosine kinase inhibitors and their current status in the treatment of chronic lymphocytic leukemia2023 | First Faculty of Medicine
- Laboratory diagnostics of muscle-specific receptor tyrosine kinase auto-antibodies in patients with myasthenia gravis without acetylcholine receptor antibodiesPublication without faculty affiliation
- Planned Discontinuation of Tyrosine Kinase Inhibitor Therapy in Metastatic Renal Cell Carcinoma: Lessons for the Era of Immunotherapy2024 | Publication without faculty affiliation
- Bruton's Tyrosine Kinase Inhibitors Ibrutinib and Acalabrutinib Counteract Anthracycline Resistance in Cancer Cells Expressing AKR1C32020 | Faculty of Pharmacy in Hradec Králové
- MicroRNAs as predictive biomarkers of response to tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma2018 | First Faculty of Medicine
- Use of Protein Tyrosine Phosphatase Inhibitors as Promising Targeted Therapeutic Drugs2009 | Third Faculty of Medicine
- Milecular diagnosis of EGFR gene mutations for biological therapy with tyrosine kinase inhibitors in patients with non-small-cell ung cancer.2010 | First Faculty of Medicine